The aim of this study was to obtain, using Magnetic Resonance Imaging (MRI), muscle volume measurements for the gluteus maximus (upper:UGM and lower:LGM portions) and tensor fascia lata (TFL) muscles in both healthy subjects (n=12) and those with unilateral osteoarthritis of the hip ( mild: n=6, and advanced: n =6). While control group subjects were symmetrical between sides for the muscles measured, subjects with hip joint pathology showed asymmetry in GM muscle volume dependent on stage of pathology. The LGM demonstrated atrophy around the affected hip in subjects with advanced pathology (p< 0.05), however asymmetry of the UGM (p<0.01) could be attributed largely to hypertrophy on the unaffected side, based on between group comparisons of muscle volume. TFL showed no significant asymmetry, or difference compared to the normal control group. This study highlights the functional separation of UGM and LGM, and the similarities of the UGM and TFL, both superficial abductors appearing to maintain their size around the affected hip. Further research is required to determine the specific changes occurring in the deeper abductor muscles. This information may assist in the development of more targeted and effective exercise programmes in the management of OA of the hip.
1 Alison Grimaldi PhD, MPhtySt, BPhty
1 Carolyn Richardson PhD, BPhty(Hons)
3 Gail Durbridge MAppSci, Grad Dip Ultrasound, DipAppSci Medical Radiography
2 William Donnelly MBBS, FRACS
1 Ross Darnell PhD
1,4 Julie Hides PhD, MPhtySt, BPhty.
- Division of Physiotherapy,
School of Health and Rehabilitation Sciences,
The University of Queensland,
Brisbane, 4072, Australia
- Brisbane Orthopaedic Specialist Services, Brisbane, Australia
- Centre for Magnetic Resonance Imaging, Brisbane, Australia
- The UQ/ Mater Back Stability Clinic
Mater Health Services,
Raymond Terrace, South Brisbane, Queensland, 4101, Australia
PUBLISHED IN MANUAL THERAPY 14 (2009) 611-617 doi:10.1016/j.math.2008.11.002
Therapeutic exercise has been cited as an important approach used in management of osteoarthritis (OA) of the hip (Altman et al 2000, Hochberg et al 1995, National Collaborating Centre for Chronic Conditions 2008, Smidt et al 2005, Zhang et al 2008). There is however, a distinct scarcity of literature investigating the effectiveness of therapeutic exercise of the hip. Programmes have often been quite generalised with small to moderate short term effects and poorer long term effects (Tak et al 2005, van Baar et al 2001). Outcomes may be improved through the development of more specific programmes based on a greater understanding of muscle function and dysfunction around the hip joint. One of the most consistent findings in subjects with hip dysfunction is an inability to maintain adequate lateral control of the hip and pelvis in single leg stance (Hardcastle & Nade 1985). Studies assessing hip abductor muscle strength in subjects with OA of the hip have found deficits of up to 31% (Arokoski et al 2002, Jandric 1997, Murray & Sepic 1968), while others have found no significant losses in abductor strength (Sims et al 2002, Teshima 1994). These apparent inconsistencies may be associated with specific changes occurring within muscles of the abductor synergy, and the association of these changes with stage of pathology.
While strength testing provides information on global abductor muscle function, a resultant effect of all synergists, specific changes within the synergy will only become evident by addressing each muscle individually. Muscles of the abductor synergy providing lateral stability of the hip and pelvis could be divided into superficial muscles that provide their effect via insertion into the iliotibial band, and deeper muscles that act via insertion into the greater trochanter. Muscles of the superficial system include the tensor fascia lata (TFL) muscle and the gluteus maximus muscle (GM) muscle. The deep system would include the gluteus medius (GMED), piriformis (PIRI) and gluteus minimus (GMIN) muscles. This paper will focus on the study of muscles of the superficial system, while the deep muscle system will be addressed in a further publication (Grimaldi et al, unpublished at this time).
In clinical rehabilitation settings, the gluteus maximus (GM) muscle has been targeted for strengthening exercises, due to its reported tendency to weaken and atrophy (Sims 1999, Janda 1983, Sahrmann 2002). In contrast, the tensor fascia lata (TFL) muscle has been targeted for lengthening techniques, due to its reported tendency to become excessively active (Sims 1999, Janda 1983, Sahrmann 2002). There has been little attention paid in either research or clinical settings, to the impact of the functional differentiation of the GM muscle on joint mechanics and the prescription of therapeutic exercise. The upper portion of the GM muscle (UGM) arises from the posterior iliac crest, while the lower portion of the GM muscle (LGM) arises from the inferior sacrum and upper lateral coccyx (Williams et al 1989). Despite a lack of fascial separation in adult humans, studies on morphogenesis of the GM muscle have revealed that it arises from two muscle primordia with a loose connective tissue separation between cranial and caudal portions in the foetus followed by fusion in the prenatal period (Tichy & Grim 1985). The UGM, acting above the centre of rotation of the hip, has a primary function of hip abduction, and does not have a role in hip extension. While both portions may externally rotate the femur, the lower portion of the gluteus maximus muscle (LGM), acting below the centre of rotation of the hip, is the primary hip extensor (Jaegers et al 1992, Stern 1972, Stern et al 1980, Lyons et al 1983) playing an important protective role in absorbing ground reaction forces at heel strike during gait.
The role of the hip abductor synergy in joint protection is less clear. While hip abductor strengthening is generally considered as a priority in patients with hip pain, an in vivo study on joint loads during gait revealed that peak joint loads were associated with peaks in hip abductor muscle activity during stance phase rather than solely loads applied from body weight (Krebs et al 1998). Contrary to common clinical belief, the authors from this study recommended that clinicians aiming to reduce joint load should reduce hip abductor activity.
Another important aspect that should be considered in the prescription of therapeutic exercise for patients with OA of the hip is the stage of pathology. While global atrophy of hip muscles may be present in end stage pathology, in the earlier stages of the condition, more specific changes in the muscles of the hip abductor synergy may occur. It has been proposed that these changes can result in alteration of the orientation of the resultant hip joint vector, and ultimately result in joint damage over time (Kummer 1993, Sims 1999). Further information pertaining to hip muscle dysfunction at different stages of pathology would be useful as it could be used in the development of more specific and possibly more effective conservative intervention or prevention programmes for those with degenerative hip joint pathology.
Subject characteristics for each group
|Mild||6||3:3||46.5 (9.5)||80.4 (15.1)||171.3(9.7)||63,667 (23,884)||25 (10.5)||41.5 *3.0)||73.2 *(11.3)|
|Adv||6||3:3||57.7 (6.7)||78.3 (8.5)||172.0 (7.4)||82,890 (75,410)||16.7 (5.2)||36.2 (5.5)||58.1 *(58.7)|
|Con||12||3:3||51.8 (9.7)||73.5 (13.3)||168.2 (10.2)||123,175 (68,766)||—-||—-||—-|
No = Number. BMI =Body Mass Index. AMI =Activity Metabolic Index
MHHS = Modified Harris Hip Score. P = Pain. F = Function
M:F = Male:Female. SD = Standard deviation. Adv = Advanced Pathology. Con = Control.
*Significant difference between pathology groups (p<0.05)
Imaging studies provide an excellent opportunity to analyse individual muscles of the hip. Only one study has measured muscle size in subjects with OA of the hip. Arokoski et al (2002) used magnetic resonance imaging (MRI) to measure hip muscle cross sectional area (CSA) in men with and without hip OA. Two axial slices through the pelvis provided a single CSA for LGM and a combined CSA of all hip abductors, including the UGM. This measure unfortunately failed to provide specific information of individual muscles of the abductor synergy. Furthermore, volume measurements rather than single slice CSA measurements, may be more representative of the complex pelvic musculature. One study has reported muscle volume measurements of the hip muscles for three healthy subjects (Jaegers et al 1992), but no volume measurements have been reported in subjects with hip OA.
The main aim of this study was to investigate size of the muscles of the superficial lateral stability mechanism of the hip, TFL and GM muscles, in subjects with either mild or advanced degenerative pathology of the hip. Subjects with unilateral pathology were selected in order to provide both within and between subject comparisons. The specific aims were to examine i) if there was significant side asymmetry in the superficial muscles across 3 groups (mild degenerative change, advanced degenerative change, matched controls), ii) if there were significant differences in actual muscle size among the pathology and control groups, and iii) if the functionally separate portions of the GM muscle, UGM, and LGM, display similar patterns of change in subjects with hip pathology. This study also examined the association of both stage of pathology, and muscle size, with the factors of age, height, weight, pain, function and activity levels.
The hypotheses of the study were that
- ia) there would be significant asymmetry in size of the UGM, LGM, and TFL in subjects with hip joint pathology, but not in controls,
- ib) asymmetry would be greater in subjects with advanced pathology,
- ii) the affected side LGM muscle would be smaller that the comparable side in control subjects, based on clinical expectation (Sahrmann 2002, Sims 1999), and
iii) changes in the UGM would more closely reflect changes in the TFL muscle based on their close functional relationship.
Twenty-four subjects (12 subjects with hip joint pathology and 12 control subjects) were recruited for this study via community advertisement and via contact with medical practitioners. Control subjects were recruited to match each subject with pathology by sex and age. The age of the control subject was required to be within 5 years of the age of the matched subject with hip pathology. There was an equal distribution of males and females in each group. Subject details are listed in Table 1.
Subjects with hip joint pathology were included in the study if they had both a medical diagnosis and radiographic evidence of unilateral degenerative hip joint pathology. Radiographic evidence included XRay or MRI demonstrating OA or atraumatic, degenerative labral pathology. OA of the hip joint was classified by an experienced radiologist using the Kellgren/Lawrence (K/L) global scoring system (Hirsch et al., 1998; Kellgren & Lawrence, 1957). Six subjects with early joint space narrowing and osteophytes (K/L grades 1-2) were recruited for the ‘Mild Group’ and 6 subjects with moderate to severe joint space narrowing and osteophytes (K/L grades 3-4) were recruited for the ‘Advanced Group’. Seven subjects had left sided pathology and five subjects had right sided pathology.
Exclusion criteria for all subjects included any systemic disease affecting the muscular or nervous system, history of congenital or adolescent hip disease, hip trauma or previous surgery, inflammatory joint disease, presence of tumour, any lower limb injuries in the previous 2 years, participation in unilateral sports, use of a walking aid, and factors that would preclude them from MRI scanning procedures (eg. pacemaker, metal implants, pregnancy, claustrophobia). Subjects in both groups were also excluded if that had experienced any lower back pain in the previous 2 years or if there had been any significant lifetime history of lower back pain that resulted in a period of immobility, or required further investigation or treatment. Subjects in the control group were excluded if they had any history of hip pain.
Information on the study was sent to the subjects prior to admission to the study. Ethical approval was obtained from the institutional review boards and informed consent was obtained from all subjects.
Side to side differences in muscle volume (cm3), and percentage differences within groups for upper gluteus maximus, lower gluteus maximus, and tensor fascia lata muscles
SD = Standard Deviation. UGM = Upper gluteus maximus muscle
LGM = Lower gluteus maximus muscle. TFL = Tensor fascia lata muscl
p<0.01 * p<0.05
Information on subject activity levels was gathered using a 12 month Leisure Time Physical Activity questionnaire providing an activity metabolic index (AMI) (Taylor et al 1978, Arokoski et al 2002). Activities were coded using the intensity code provided (Taylor et al 1978).The AMI for each activity the subject participated in was calculated with the formula: AMI = Intensity code (mean metabolic units) x average number of times per month x the number of months per year (frequency) x the time the activity was performed per occasion (duration). Total AMI reflects the addition of AMI for all activities (Taylor et al 1978) and provides a measure of metabolic units used/year.
The Modified Harris Hip Score (MHHS) was used to assess pain and function in the subjects with OA of the hip (Byrd & Jones 2000). The pain section consisted of 44 points, where a score of 44 represents a pain-free state. The function section consisted of 47 points, where a score of 47 points represents full, normal function. The multiplier 1.1 was used to achieve a total score out of a possible 100 (pain-free normal function).
Fig.1. Diagramatic representation of the portions of the GMmuscle.
UGM LGM ITB
Testing of Leg Domnance.
Subjects were also tested for leg dominance. Kicking was used as the test function (Herneth et al 2004). The weight-bearing leg was recorded as “stance dominant” and the kicking leg as the “skill dominant” leg.
Subjects were first screened for contraindications to MRI by a medical practitioner. Subjects were positioned in supine lying with legs extended to a neutral position. Leg rotation was controlled with the use of sand bags. A 1.5 Tesla Siemens Sonata MR system was used. A T2 True FISP sequence using 2 series of 28 x 6 mm contiguous slices from the iliac crest to the most distal extent of the gluteus maximus muscle was employed (TR: 3.78ms/TE:1.89ms/FOV:390mm).
An MRI measurement software package (Osiris) was used to measure CSA (cm2) of UGM, LGM and TFL muscles on each image in which the muscle appeared. Muscle volume (cm3) was calculated by multiplying CSA by slice width and then adding the volumes from each slice to determine the total muscle volume (Fukunaga et al 1992, Alkner & Tesch 2004) (Figure 2).The two functionally separate parts of GM were measured (UGM and LGM). The UGM includes that part of the muscle acting above the centre of rotation of the femoral head. These fibres insert almost exclusively into the iliotibial band (ITB) via a thick laminar tendon (Lieberman et al 2006). The LGM inserts below the centre of rotation, superficial fibres into the ITB, deep fibres into the gluteal ridge of the femur (Lieberman et al 2006). This anatomy is depicted in Figure 1. In this study the largest CSA of the femoral head was used as an anatomical landmark to functionally separate the UGM from the LGM muscle, to approximate the centre of rotation of the femoral head (Stern 1972).
Reliability of the assessor’s measurement technique was tested by retracing all slices of one subject (44slices) with an interim period of 6 weeks. Intra-tester reliability was tested for each separate measurement on each slice using a two sided bootstrapped interval of intraclass correlation coefficient (ICC2,1). Intra-rater reliability was found to be good, with correlation coefficients ranging from 0.87 to 0.99. Standard error of measurement (SEM) was calculated using the formula SEM= pooled SD x (1-ICC) ½ (Wallwork et al 2007). Standard deviation of the difference (SDD) was also calculated as the standard deviation of the differences between measurement 1 and 2. SEM for the GM muscle was 0.495cm2 and the SDD was 3.87cm2, while for the TFL muscle the SEM was 0.536cm2 and the SDD was 2.44cm2. These values represent good measurement stability with low error.
The comparison of muscle volumes among groups and between sides was performed using a mixed linear model describing muscle volume with group as a between-subject factor, and side as a within-subject factor (Dependent variable=muscle volume, Independent variables=sides & groups). Each muscle was analysed separately. Contrasts of means were performed to compare sides within groups. Muscle volumes around the affected and unaffected hips of the subjects with hip joint pathology were compared with muscle volumes of the corresponding sides of their matched control subjects. That is, if the pathological side was left, the left side muscle volume of the matched control subject was used for comparison, and the right compared with the unaffected side value of the pathology group counterpart. Percent differences were calculated using the formula: % Difference= [ (larger value-smaller value)/larger value] * 100 (Hides et al 1996).
Analyses were also conducted to assess participant characteristics in relation to
- a) the similarity of the groups and
- b) the extent of association with muscle size.
One way analysis of variance was used to assess group equivalence across each of the dependent measures of age, height, weight, pain, function, and metabolic activity. The association between these patient characteristics and UGM, LGM, or TFL muscle size was assessed using analysis of covariance.
2A. Through ilia showing UGM in the proximal pelvis
Figure 2: Axial MRIs through the pelvis
Side to side differences in muscle volumes within groups
There were no significant side to side differences in the control or mild pathology groups. While LGM size was smaller on the affected side in all but one subject in the group with mild joint changes, the asymmetry was not great enough to be statistically significant. In the group with advanced pathology there were significant between side differences in the GM but not the TFL muscle. The asymmetry was greater in the UGM muscle (mean difference 21%, p<0.01) than the LGM muscle (mean difference 19.7%, p<0.05). Means, standard deviations, and percentage difference in muscle volumes are reported for each group in Table 2. Examples of side to side differences are illustrated for each group in Figure 2.
Differences in muscle volumes between groups
No significant differences in muscle volumes were found between the mild and advanced pathology groups. The UGM muscles were significantly larger on the unaffected side (Mean difference 30.5%) of the subjects in the advanced pathology group when compared with matched controls (p<0.05, Table 3). No other comparisons reached statistical significance Although LGM volumes were on average 15.2% larger (p=0.12) on the unaffected side in the group with advanced pathology, compared with controls, statistical analysis did not reveal a significant difference in this relatively small sample size. Means, standard deviations, and percentage difference in muscle volumes around matched hips of the pathology and control groups are reported in Table 3.
Results of the AMI for all subjects and the MHHS for subjects with OA of the hip are shown in Table 1. Pain and function scores were lower for the group with more advanced radiological changes, reflecting higher pain levels and more functional disability, as measured by the MHHS. These scores considered alone were not significantly different statistically, however when the total score was calculated there was a significant difference between scores in the mild and advanced pathology groups (p<0.05). There was no statistically significant difference between groups for the AMI.
All subjects were left stance dominant/right skill dominant.
Effect of subject characteristics on muscle size
Results of the analyses indicated the groups were comparable in terms of age, height, weight, and metabolic activity (all p>0.05). In addition there was no significant relationship between these patient characteristics, or pain and function, and UGM, LGM or TFL muscle volume (p>0.05).
Between group differences in muscle volume (cm3) for upper gluteus maximus, lower gluteus maximus, and tensor fascia lata muscles
UGM =Upper gluteus maximus muscle. LGM =Lower gluteus maximus muscle. TFL=Tensor fascia lata muscle. SD=Standard Deviation. Side refers to the named side in the pathology group, and for the control group side is aligned by matched pair dependent on side of pathology; 1Reference group for significance values; * p <0.05
This study investigated the influence of degenerative hip joint pathology on size of the GM and TFL muscles.
Side to side differences in muscle volumes within groups
The results of this study showed that subjects with demonstrated unilateral hip joint pathology exhibited marked side to side differences in the size of the GM muscle, specific to stage of pathology. While asymmetry in LGM size in subjects with mild joint pathology was not great enough to be statistically significant, in those with advanced joint changes the mean volume of the LGM muscle was on average 19.7% smaller on the affected side (p<0.05). The only previous study to investigate muscle size in those with OA of the hip/s reported that the mean CSA of the LGM muscle was 9% smaller on the side of the worse hip in those with either unilateral or bilateral OA (Arokoski et al 2002). The most likely explanations for the smaller percent difference are the inclusion of subjects with bilateral pathology in the latter study which would be expected to reduce the degree of side to side difference demonstrated, and the inclusion of subjects with both mild and advanced joint pathology in the analysis. Some explanation may also be provided by the different measurement techniques. A single CSA measurement may not provide a true reflection of change in total muscle volume.
The UGM muscle similarly showed no significant side to side difference in those with mild joint pathology. In the presence of advanced pathology, the UGM was on average 21% smaller on the affected side, representing a significant side to side difference in muscle size (p<0.01).
The TFL muscle was not significantly different between sides in either pathology group, although the mild group was on average 10.5% larger on the affected side. In contrast Arokoski et al (2002) reported that the CSA of the TFL muscle was 13% smaller on the more affected side in men with OA. This difference is again most likely due to differences in subject selection and/or measurement technique.
Another important consideration when interpreting side to side differences in muscle size is that in the absence of longitudinal data, the determination of side to side differences as atrophy or hypertrophy around weight-bearing joints must be approached with caution. Side to side differences could reflect either atrophy or hypertrophy. Decreases in muscle size on the affected side could occur in response to pain (Lund et al 1991) or reflex inhibition (Stokes & Young 1984). However, as pain causes an instinctive shift in weight-bearing towards the unaffected side, side to side volume differences may occur due to disuse atrophy around the affected hip and/or overuse hypertrophy of the unaffected side. For this reason, a control group was included for comparison of actual muscle volumes between groups, thereby assisting in the interpretation of side to side differences.
Differences in muscle volumes between groups
As with the Arokoski et al study (2002), the current study was unable to demonstrate any between group difference in LGM size. This may be due simply to the inherent variability within the population and the relatively small sample size. Another consideration is the fact that the measurement of muscle size by tracing around the perimeter of a muscle in the subjects with pathology of the hip joint may underestimate the loss of contractile muscle tissue. Replacement of normal viable muscle tissue with intramuscular fatty or connective tissue has been reported as ‘fatty atrophy’ at the hip in the gluteus medius muscle (Pfirrmann et al 2005). Differences in tissue quality of the LGM muscle are observable as increased black markings within the muscle on the side of the affected hip in Fig 1D and 1F. This assists in the support of the assumption that side to side differences in the LGM muscle in those with hip pathology are at least in part due to atrophy around the affected hip. It is most likely however that together with atrophy around the affected hip, there may be concurrent hypertrophy of the unaffected side LGM secondary to patterns of antalgic weight shift. The finding that advanced group subjects LGM volumes were 15.2% larger on the unaffected side than matched control subjects (p=0.12), provides some support for this effect although not reaching statistical significance.
Between group differences for the UGM muscle showed that the mean muscle volume of the UGM muscle on the unaffected side in those with advanced pathology was significantly (Mean difference 30.5%) larger than the corresponding muscles in the control group subjects. This finding suggests that the significant asymmetry (Mean difference 21%) observed in subjects with advanced joint pathology may be largely attributable to hypertrophy on the unaffected side. Some degree of atrophy on the affected side however cannot be discounted although fatty atrophy was not commonly observed in the UGM muscle. Around the affected hip neither the UGM muscle, or the other superficial hip abductor, the TFL muscle, were significantly different in size to a normal population.
The other information that was assessed with regard to the subjects of this study was gathered through self report questionnaires and leg dominance testing. While pain, function and leg dominance had no significant effect on GM or TFL muscle size, the information collected provided 2 important pieces of information.
Pain, function & radiological change
The first of these relate to the association between pain, function, and radiological change.
It has been previously noted that there is often no clear relationship between severity of radiological change in an osteoarthritic joint and severity of pain or degree of disability (Hurley 1999). In studies of subjects with OA of the knee, advanced radiological change may in some people be accompanied by very little pain, while others with only mild degenerative change may experience severe disabling pain (Claessens et al 1990; McAlindon et al 1993). Arokoski et al (2002) in their study of men with OA of the hip were unable to demonstrate a correlation between grade of severity of OA and pain measured on a visual analogue scale. There was however significantly more pain within individuals on the side with the highest radiographic OA score. Similarly the findings of the current study reflect the difficulty in linking a pain score alone to degree of radiographic change. By combining measures of pain and function, the Modified Harris Hip Score was able to demonstrate significant differences between subjects with early radiographic change and those with advanced radiographic change. This may suggest that this particular combination of questions may be more sensitive to degree of radiographic change than those available for OA of the knee.
The influence of leg dominance
The second finding of importance relates to the potentially confounding variable of leg dominance. Although there is evidence that dominance has an effect on muscle strength (Balogen & Onigbinde 1992), particularly in upper limb strength in those involved in unilateral sports (Ducher et al 2005; Ellenbecker et al 2006), there is a much weaker link between leg dominance and muscle strength (Hunter et al 2000; Zakas 2006), and little evidence to link leg dominance to asymmetry in muscle size. Greater muscle strength of the dominant limb may be associated with improved neuromuscular functioning, rather than muscle size alone. In the current study the exclusion of all subjects involved in unilateral sports sought to avoid the effect of this potentially confounding variable on muscle symmetry. The results of this study were able to demonstrate that for the normal control subjects tested there was no significant asymmetry in muscle size for the muscles measured. All subjects were left stance dominant which, if this factor were imparting an effect, would favour a larger muscle volume on the left side particularly for the weightbearing LGM muscle. This was not the case, allowing greater clarity in interpretation of results for the pathology groups.
Possible Clinical Implications
The balance of muscle activity around a joint may either protect a joint from injury or accelerate destructive joint forces. Both the UGM and LGM muscles are known to be active at heel strike in gait to help absorb ground reaction forces causing lateral pelvic drop and flexion moments at the hip and knee (Stern et al 1980, Lyons et al 1983). While reduced activation of the GM muscle may fail to absorb these ground reaction forces, excessive activation in the abductor muscles, may lead to an increase in joint loading (Krebs et al 1998). So both atrophy of the LGM muscle around the affected hip, and hypertrophy of the UGM muscle around the unaffected hip may have negative effects on their respective underlying joints. Hurley (1999) has suggested that the presence of bilateral muscle dysfunction may help explain why unilateral OA years later often becomes bilateral OA. The findings of this study imply that the LGM and UGM muscles should be assessed individually, and on both sides, with clinical management directed towards restoring normal symmetrical weight-bearing patterns and muscle bulk.
Further, the finding that neither of the superficial hip abductor muscles appear to be affected on the side of pathology, and recommendations to reduce recruitment of the hip abductor muscles in order to reduce peak acetabular pressures during gait (Krebs et al 1998), the current clinical rationale for generalised hip abductor muscle strengthening could be questioned. While some authors have reported hip abductor muscle strength deficits of up to 31% (Arokoski et al 2002, Jandric 1997, Murray & Sepic 1968), others have reported no significant difference (Sims 2002, Teshima 1994). These variable findings may be a reflection of the relative degrees of atrophy of individual muscles of the abductor synergy. If both superficial abductor muscles are not significantly affected by pathology, strength changes may possibly reflect weakness in the deeper abductor muscles. Together with the information provided by this study, further information on the response of the deep muscle system to degenerative change of the hip may provide further insight into specific changes within the abductor synergy. Greater specificity in exercise prescription around the hip may allow development of interventions that achieve more significant and longer lasting changes in pain and function scores in patients with OA of the hip.
Limitations and Future Directions
The main limitation of this study was low subject numbers. Valuable additional information may be gained by subsequent studies with larger subject numbers and the inclusion of a method to measure quality of muscle tissue. Furthermore, this study assessed only two of many hip muscles which may be associated with hip pathology. Further investigation of other muscles, such as the deeper abductor muscles, is required to provide a more complete picture of muscle dysfunction.
This study has demonstrated that the gluteus maximus muscle should be considered as 2 functionally separate entities, the UGM a hip abductor and the LGM, a hip extensor, these muscles having differing responses to the presence of joint pathology. The UGM muscle like its functional counterpart, the TFL, is unaffected by the presence of joint pathology, while the LGM muscle demonstrates local atrophy. The lack of affect on the superficial hip abductors suggests that muscle weakness demonstrated in subjects with OA of the hip may be related to changes in the deeper hip abductors (GMED, GMIN and PIRI) and require more specific therapeutic exercise intervention.
Alkner BA, Tesch PA. Knee extensor and plantar flexor muscle size and function following 90 days of bed rest with or without resistance exercise. European Journal of Applied Physiology 2004; 93:294-305
Altman RD, Hochberg MC, Moskowitz RW, Schnitzer TJ. Recommendations for the medical management of osteoarthritis of the hip and knee:2000 update. Arthritis & Rheumatism 2000; 43:1905-1915
Arokoski MH, Arokoski JPA, Haara M, Kankaanpaa M, Vesterinen M, Niemitukia LH, et al. Hip muscle strength and muscle cross sectional area in men with and without hip osteoarthritis. Journal of Rheumatology 2002; 29:2185-95
Balogen JA, Onigbinde AT. Hand and leg dominance: do they really affect limb muscle strength? Physiotherapy Theory & Practice 1992; 8(2):89-96.
Byrd JWT, Jones KS. Prospective analysis of hip arthroscopy with 2-year follow up. Arthroscopy 2000; 16(6):578-587
Claessens AA, Schouten JS, van den Ouweland FA, Valkenburg HA. Do clinical findings associate with radiographic osteoarthritis of the knee? Annals of the Rheumatic Diseases 1990; 49:771-774
Ellenbecker TS, Roetert EP, Riewald S. Isokinetic profile of wrist and forearm strength in elite female junior tennis players. British Journal of Sports Medicine 2006; 40:411-414.
Fukunaga T, Roy RR, Shellock FG, Day MK, Lee PL, Kwong-Fu H, Edgerton VR. Physiological cross-sectional area of human leg muscles based on magnetic resonance imaging. Journal of Orthopedic Research 1992; 10(6):926-934
Hardcastle P, Nade S. The significance of the trendelenberg test. Journal of Bone and Joint Surgery British 1985; 67B: 741-746
Herneth A, Philip M, Pretterklieber M, Balassy C, Winkelbauer F, Beaulieu C. Asymmetric closure of ischiopubic synchondrosis in pediatric patients: correlation with foot dominance. American Journal of Radiology 2004; 182(2):361-5
Hochberg MC, Altman RD, Brandt KD, Clark BM, Dieppe PA, Griffin MR, et al.
Guidelines for the medical management of osteoarthritis. Part 1. Osteoarthritis of the hip. Arthritis & Rheumatism 1995;38:1535-40
Hides JA, Richardson CA, Jull GA. Multifidus muscle recovery is not automatic after resolution of acute, first-episode low back pain. Spine 1996; 21(23): 2763-9
Hirsch R, Fernandes RJ, Pillemer SR, Hochberg MC, Lane NE, Altman RD, Bloch DA, Knowler WC, Bennett PH. Hip osteoarthritis prevalence estimates by three radiographic scoring systems. Arthritis & Rheumatism 1998; 41(2):361-368.
Hunter SK, Thompson MW, Adams RD. Relationships among age-associated strength changes and physical activity level, limb dominance, and muscle group in women. Journal of Gerentology 2000; 55A(6):B246-272.
Hurley MV. The role of muscle weakness in the pathogenesis of osteoarthritis. Rheumatic Disease Clinics of North America 1999; 25(2):283-298
Jaegers S, Dantuma R, deJongh H. Three dimensional reconstruction of the hip on the basis of magnetic resonance images. Surgical Radiologic Anatomy 1992; 14:241-9
Jandric S. Muscle parameters in coxarthrosis. Medicinski Pregled 1997; 50(7-8):301-4
Janda V. Muscle function testing. London, Boston: Butterworths; 1983
Kellgren, J., & Lawrence, J. Radiological assessment of osteoarthritis. Annals of the Rheumatic Diseases 1957; 16:494-502
Krebs DE, Robbins CE, Lavine L, Mann RW. Hip biomechanics during gait. Journal of Orthopedic and Sports Physical Therapy 1998; 28(1): 51-59
Kummer B. Is the Pauwels theory of hip biomechanics still valid? A critical analysis, based on modern methods. Annals of anatomy 1993; 175:203-10
Lieberman, D., Raichlen, D., Pontzer, H., Bramble, D., & Cutright-Smith, E. The human gluteus maximus and its role in running. The Journal of Experimental Biology 2006; 209(11):2143-2155
Lund JP, Donga R, Widmer CG, Stohler CS. The pain-adaptation model: a discussion of the relationship between chronic musculoskeletal pain and motor activity. Canadian Journal of Physiology and Pharmacology 1991; 69(5):683-94
Lyons K, Perry J, Gronley JK, Barnes L, Antonelli D. Timing and relative intensity of hip extensor and abductor muscle action during level and stair ambulation. Physical Therapy 1983; 63(10):1957-605
Marsh LM, Bagga H. Epidemiology of osteoarthritis in Australia. Medical Journal of Australia 2004; 180(Supplement):S6-S17
McAlindon TE, Cooper C, Kirwan JR, Dieppe PA. Determinants of disability in osteoarthritis of the knee. Annals of the Rheumatic Diseases 1993; 52:258-262.
Murray MP, Sepic SB. Maximum isometric torque of hip abductor and adductor muscle. Physical Therapy 1968; 48:1327-35
National Collaborating Centre for Chronic Conditions. Osteoarthritis: national clinical guideline for care and management in adults. London: Royal College of Physicians, 2008.
Pfirrmann CWA, Notzli HP, Dora C, Hodler J, Zanetti. Abductor tendons and muscle assessed at MR imaging after total hip arthroplasty in asymptomatic and symptomatic patients. Radiology 2005; 235:969-976
Sahrmann S. Diagnosis and treatment of movement impairment syndromes. St Louis: Mosby; 2002
Smidt N, de Vet HCW, Bouter LM, Dekker J for the Exercise Therapy Group. Effectiveness of exercise therapy: A best evidence summary of systematic reviews. Australian Journal of Physiotherapy; 51:71-83.
Sims K, Richardson CA, Brauer SG. Investigation of hip abductor activation in subjects with clinical unilateral osteoarthritis. Annals of the Rheumatic Diseases 2002; 61:687-92
Sims K. The development of hip osteoarthritis: implications for conservative management. Manual Therapy 1999; 4:127-35
Stern JT. Anatomical and functional specializations of the human gluteus maximus. American Journal of Physical Anthropology 1972; 36:315-40
Stern JT, Pare EB, Schwartz JM. New perspectives on muscle during locomotion.
Electromyographic studies of rapid and complex behaviours. Journal of the American Orthopedic Association 1980; 80(4):287-91
Stokes M, Young A. the contribution of reflex inhibition to arthrogenous muscle weakness. Clinical Science 1984; 67(1):7-14
Tak E, Staats P, van Hespen A, Hopman-Roc, M. The effects of an exercise programme for older adults with osteoarthritis of the hip. The Journal of Rheumatology 2005; 32: 1106-1113
Taylor HL, Jacobs DR, Schucker B, Knudsen J, Leon AS, Debacker G. A questionnaire for the assessment of leisure time activities. Journal of Chronic Diseases 1978; 31:741-755
Teshima K. Hip abduction force in osteoarthritis of the hip. Acta Medica Nagasakiensia 1994; 39(3):21-30
Tichy M, Grim M. Morphogenesis of the human gluteus maximus muscle arising from two muscle primordia. Anatomy and Embrology 1985; 173(2): 275-277
van Baar M, Dekker J, Oostendorp R, Bijl D, Voorn T, Bijlsma J. Effectiveness of exercise in patients with osteoarthritis of hip or knee: nine months’ follow up. Annals of the Rheumatic Diseases 2001; 60: 1123-1130
Wallwork TL, Hides JA, Stanton WR. Intrarater and interrater reliability of assessment of lumbar multifidus muscle thickness using rehabilitative ultrasound imaging. Journal of Orthopedic and Sports Physical Therapy 2007; 37(10): 608-612
Williams P, Warwick R, Dyson M, Bannister L. Grays anatomy (37th ed.). Edinburgh: Churchill Livingstone; 1989
Zakas A. Bilateral isokinetic peak torque of quadriceps and hamstring muscles in professional soccer players with dominance on one or both two sides. Journal of Sports Medicine and Physical Fitness 2006; 46:28-35.
Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis and Cartilage 2008; 16:137-16 UGM =Upper gluteus maximus muscle. LGM =Lower gluteus maximus muscle. TFL=Tensor fascia lata muscle. SD=Standard Deviation. Side refers to the named side in the pathology group, and for the control group side is aligned by matched pair dependent on side of pathology; 1Reference group for significance values; * p